The number of layoffs in the U.S. pharmaceutical industry continued at a brisk r...
Here's what to know about the upcoming FDA committee hearing on Sarepta's gene t...
"Both [drugmakers and PBMs] share major responsibility for the outrageously high...
“I think we’re behind, and it’s going to be really hard to catch up,” FDA Commis...
Clearly, legislative policy has not kept pace with the rapid evolution in drug d...
"Sam is also caring for me a lot of the time, especially if I let him. He tells ...
Basically anyone can call themselves a “health coach” and start taking on clients.
EQRx, a company that aimed to lower drug prices by introducing inexpensive me-to...
This week's Health Care Inc. tackles the "why" behind the Kaiser Permanente-Geis...
Amid rising demand for drugs like Wegovy and Ozempic that can lead to significan...
For the first time, the U.S. government will pay for a large study measuring whe...
There is emerging consensus among rare-disease physicians that genomic sequencin...
Major age-related illnesses hit most centenarians about 20 to 30 years later tha...
An FDA advisory panel will meet this week to review an application by Perrigo to...
What will happen should we see a repeat of the tripledemic this upcoming winter?
New Method Uses Engineered Bacteria and AI to Sense and Record Environmental Sig...
